デフォルト表紙
市場調査レポート
商品コード
1462937

同種幹細胞移植の世界市場:細胞タイプ別、由来別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024~2032年)

Allogeneic Stem Cell Transplantation Market, By Cell Type, By Source, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 299 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
同種幹細胞移植の世界市場:細胞タイプ別、由来別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024~2032年)
出版日: 2024年04月14日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の同種幹細胞移植の市場規模は、2023年に38億3,334万米ドルに達し、2024~2032年にかけてCAGR 7.8%で拡大すると予測されています。

同種幹細胞移植市場 - 市場力学

血液悪性腫瘍および非悪性疾患の有病率の上昇が市場需要を促進

同種幹細胞移植市場は、この移植法が有望視されている血液悪性腫瘍および非悪性疾患の有病率の上昇によって、大幅な成長が見込まれます。さらに、研究開発への投資の増加や幹細胞治療の充実したパイプラインが市場拡大を後押しすると予想されます。様々な治療領域で同種幹細胞移植を模索する臨床試験が増加していることは、将来の市場成長にとって良い兆しです。がん、自己免疫疾患、血液疾患などの慢性疾患の罹患率の増加は、同種幹細胞移植市場の主要な促進要因です。白血病、多発性骨髄腫、リンパ腫などの疾患は過去10年間で着実に増加しています。同種幹細胞移植は、これらの高リスクかつ薬剤耐性の血液悪性腫瘍の多くに対して、治癒の可能性のあるアプローチを提供します。世界保健機関(WHO)によると、2020年には世界中でがんによる死亡が1,000万人近くにのぼるといいます。患者数が増加し、これらの病態に対処するための先進的な治療法に対する需要が高まっていることが、市場成長の原動力となると思われます。従来の血液がんや疾患にとどまらない新たな用途への同種幹細胞治療の安全性と有効性を評価するため、数多くの調査や臨床試験が進行中です。骨髄線維症、変形性関節症、脳卒中、外傷性脳損傷、心筋炎などの疾患に対する同種幹細胞治療が、いくつかの第2相および第3相臨床試験で検討されています。治療の展望を広げることを目的とした強力なパイプライン活動は、市場成長の新たな道を切り開くと思われます。例えば、世界の製薬企業であるノバルティスは、骨髄線維症の治療に同種幹細胞移植を用いる第2相臨床試験を開始し、2024年10月の完了を目指しています。

同種幹細胞移植市場 - 主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024~2032年)にCAGR 約7.8%で毎年成長すると推定されます。

由来別では、骨髄は2023年に最大の市場シェアを示すと予測されました。

エンドユーザー別では、病院が2023年の主要タイプでした。

地域別では、北米が2023年の売上高をリードしています。

同種幹細胞移植市場 - セグメンテーション分析:

世界の同種幹細胞移植市場は、細胞タイプ、由来、用途、エンドユーザー、地域に基づいて区分されます。

同市場は、由来に基づいて2つのカテゴリーに分けられます:骨髄、末梢血、臍帯血、脂肪組織、歯髄、その他。骨髄同種幹細胞移植市場は、2023年に大きな世界市場シェアを獲得する見通しです。骨髄幹細胞移植は、特定の血液疾患、特に従来の治療法が無効であることが証明された場合、または疾患の再発が起こった場合の有望な治療手段として浮上しています。対象となる患者にとって、この治療法は余命を大幅に延長する可能性があり、多くの場合再発の心配がないため、最も重要な意味を持っています。

市場はエンドユーザー別に病院、調査機関、専門クリニック、その他に分類されます。2023年において、病院のエンドユーザー部門は同種幹細胞移植サービスに大きく寄与しているが、これは主に近代的な病院内で利用可能な高度な医療インフラのためです。特に、現代の病院には、骨髄移植に特化した専門ユニットなど、最先端の医療技術が備わっています。これらの資源は、特に米国、ドイツ、英国、中国、インドなどの地域において、病院が造血幹細胞移植(HSCT)レシピエントに移植前後の包括的なケアを提供するための力となっています。

同種幹細胞移植市場 - 地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

同種幹細胞移植市場 - 競合情勢:

企業やヘルスケア機関は、患者の転帰を向上させ、イノベーションを促進し、移植サービスへのアクセスを強化するための戦略的施策を実施しています。この戦略の重要な側面には、献身的な研究開発努力による移植技術とプロトコルの継続的な進歩が含まれます。これには、移植片対宿主病(GVHD)に対する革新的な予防法への投資、コンディショニングレジメンの改良、適格基準を拡大し移植成功率を高めるための代替幹細胞源の探求などが含まれます。学術機関や研究機関との協力は、これらの進歩を検証し最適化する上で重要な役割を果たし、臨床への適用と有効性を確実なものにしています。

目次

第1章 同種幹細胞移植の市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 同種幹細胞移植の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 同種幹細胞移植産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 同種幹細胞移植市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 同種幹細胞移植の市場情勢

  • 同種幹細胞移植市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存プレイヤーの分析
    • 新興プレーヤーの分析

第7章 同種幹細胞移植市場 - 細胞タイプ別

  • 概要
    • セグメントシェア分析(細胞タイプ別)
    • 同種MSC
    • 同種造血幹細胞
    • その他

第8章 同種幹細胞移植市場 - 由来別

  • 概要
    • セグメントシェア分析(由来別)
    • 骨髄
    • 末梢血
    • 臍帯血
    • 脂肪組織
    • 歯髄
    • その他

第9章 同種幹細胞移植市場 - 用途別

  • 概要
    • セグメントシェア分析(用途別)
    • がん
    • 自己免疫疾患
    • 血液疾患
    • 心臓疾患
    • 神経疾患
    • 糖尿病
    • その他

第10章 同種幹細胞移植市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析(エンドユーザー別)
    • 病院
    • 研究機関
    • 専門クリニック
    • その他

第11章 同種幹細胞移植市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 同種幹細胞移植産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Celgene Corporation
    • Mesoblast Ltd.
    • Pluristem Therapeutics Inc.
    • MEDIPOST Co., Ltd.
    • Osiris Therapeutics, Inc.
    • Cynata Therapeutics Limited
    • Takeda Pharmaceutical Company Limited
    • Astellas Pharma Inc.
    • Cellular Biomedicine Group, Inc.
    • Biosolution Co., Ltd.
    • StemCell Technologies Inc.
    • Caladrius Biosciences, Inc.
    • ViaCord
    • Vericel Corporation
    • Regen Biopharma Inc.
    • Gamida Cell Ltd.
    • Histogenics Corporation
    • BrainStorm Cell Therapeutics Inc.
    • Lineage Cell Therapeutics, Inc.
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Allogeneic Stem Cell Transplantation Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Source Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Source 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2395

REPORT HIGHLIGHT

Allogeneic Stem Cell Transplantation Market size was valued at USD 3,833.34 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

Allogeneic stem cell transplantation involves the transfer of healthy stem cells from a genetically compatible donor to the patient, replacing damaged cells. This established therapeutic technique is used to address various hematological cancers, blood disorders, and immunological conditions. Stem cells for allogeneic transplants can be sourced from peripheral blood, bone marrow, umbilical cord blood, or adipose tissue. The field has witnessed significant progress in harvesting methods, expansion protocols, cryopreservation, and cell processing.

Allogeneic Stem Cell Transplantation Market- Market Dynamics

Rising prevalence of hematologic malignancies and non-malignant disorders to propel market demand

The Allogeneic Stem Cell Transplantation Market is expected to witness substantial growth driven by the rising prevalence of hematologic malignancies and non-malignant disorders, where this transplantation method has shown promise. Additionally, increased investments in research and development, along with a robust pipeline of stem cell therapies, are anticipated to propel market expansion. The rising number of clinical trials exploring allogeneic stem cell transplantation across various therapeutic areas bodes well for future market growth. The increasing incidence of chronic diseases like cancer, autoimmune disorders, and blood ailments is a key driver for the allogeneic stem cell transplantation market. Cases of diseases such as leukemia, multiple myeloma, and lymphoma have steadily risen over the past decade. Allogeneic hematopoietic stem cell transplantation offers a potentially curative approach for many of these high-risk and drug-resistant hematological malignancies. According to the World Health Organization (WHO), cancer caused nearly 10 million deaths worldwide in 2020. The growing pool of patients and demand for advanced therapies to address these conditions will fuel market growth. Numerous research studies and clinical trials are underway to assess the safety and efficacy of allogeneic stem cell therapies for new applications beyond traditional blood cancers and disorders. Several phase 2 and 3 trials are investigating allogeneic stem cell therapies for conditions such as bone marrow fibrosis, osteoarthritis, stroke, traumatic brain injury, and myocarditis, among others. Robust pipeline activities aimed at expanding the treatment landscape will open up new avenues for market growth. For example, Novartis, a global pharmaceutical company, has initiated a phase 2 clinical trial using allogeneic stem cell transplantation to treat bone marrow fibrosis, with an expected completion date of October 2024.

Allogeneic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Source segmentation, Bone Marrow was predicted to show maximum market share in the year 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Allogeneic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Allogeneic Stem Cell Transplantation Market is segmented on the basis of Cell Type, Source, Application, End User, and Region.

The market is divided into two categories based on Source: Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others. The bone marrow allogeneic stem cell transplantation market is poised to command a significant global market share in 2023. Bone marrow stem cell transplantation emerges as a promising therapeutic avenue for select hematological disorders, particularly in cases where conventional treatments have proven ineffective or disease recurrence has transpired. For eligible individuals, this treatment modality holds paramount importance as it offers the potential to extend life expectancy significantly, often free from relapse.

The market is divided into three categories based on End User: Hospitals, Research Institutes, Specialty Clinics, and Others. In 2023, the hospital end user segment predominantly contributes to allogeneic stem cell transplantation services, primarily owing to the sophisticated medical infrastructure available within modern hospitals. Notably, contemporary hospitals are equipped with cutting-edge medical technologies, including specialized units dedicated to bone marrow transplantation. These resources empower hospitals to deliver comprehensive pre- and post-transplant care to hematopoietic stem cell transplant (HSCT) recipients, particularly in regions such as the United States, Germany, the United Kingdom, China, and India.

Allogeneic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Allogeneic Stem Cell Transplantation Market- Competitive Landscape:

Companies and healthcare institutions are implementing strategic measures to enhance patient outcomes, foster innovation, and enhance access to transplantation services. A crucial aspect of this strategy involves continual advancements in transplant technologies and protocols through dedicated research and development endeavors. This encompasses investments in innovative prophylaxis methods for graft-versus-host disease (GVHD), refinement of conditioning regimens, and exploration of alternative stem cell sources to broaden eligibility criteria and enhance transplant success rates. Collaborations with academic institutions and research organizations play a vital role in validating and optimizing these advancements, ensuring their clinical applicability and effectiveness.

Recent Developments:

In September 2023, MaaT Pharma, a biotechnology company based in France, announced that the European Medicines Agency (EMA) has granted orphan drug designation to MaaT033. Developed by MaaT Pharma, MaaT033 is an adjunctive and maintenance therapy aimed at improving overall survival in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Celgene Corporation

Mesoblast Ltd.

Pluristem Therapeutics Inc.

MEDIPOST Co., Ltd.

Osiris Therapeutics, Inc.

Cynata Therapeutics Limited

Takeda Pharmaceutical Company Limited

Astellas Pharma Inc.

Cellular Biomedicine Group, Inc.

Biosolution Co., Ltd.

StemCell Technologies Inc.

Caladrius Biosciences, Inc.

ViaCord

Vericel Corporation

Regen Biopharma Inc.

Gamida Cell Ltd.

Histogenics Corporation

BrainStorm Cell Therapeutics Inc.

Lineage Cell Therapeutics, Inc.

Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

  • Allogeneic MSCs
  • Allogeneic HSCs
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Bone Marrow
  • Peripheral Blood
  • Umbilical Cord Blood
  • Adipose Tissue
  • Dental Pulp
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Autoimmune Diseases
  • Blood Disorders
  • Cardiac Disorders
  • Neurological Disorders
  • Diabetes
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Research Institutes
  • Specialty Clinics
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Allogeneic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Allogeneic Stem Cell Transplantation Market Snippet by Cell Type
    • 2.1.2.Allogeneic Stem Cell Transplantation Market Snippet by Source
    • 2.1.3.Allogeneic Stem Cell Transplantation Market Snippet by Application
    • 2.1.4.Allogeneic Stem Cell Transplantation Market Snippet by End User
    • 2.1.5.Allogeneic Stem Cell Transplantation Market Snippet by Country
    • 2.1.6.Allogeneic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Allogeneic Stem Cell Transplantation Key Market Trends

  • 3.1.Allogeneic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Allogeneic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Allogeneic Stem Cell Transplantation Market Opportunities
  • 3.4.Allogeneic Stem Cell Transplantation Market Future Trends

4.Allogeneic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Allogeneic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Allogeneic Stem Cell Transplantation Market Landscape

  • 6.1.Allogeneic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Allogeneic Stem Cell Transplantation Market - By Cell Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 7.1.2.Allogeneic MSCs
    • 7.1.3.Allogeneic HSCs
    • 7.1.4.Others

8.Allogeneic Stem Cell Transplantation Market - By Source

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2.Bone Marrow
    • 8.1.3.Peripheral Blood
    • 8.1.4.Umbilical Cord Blood
    • 8.1.5.Adipose Tissue
    • 8.1.6.Dental Pulp
    • 8.1.7.Others

9.Allogeneic Stem Cell Transplantation Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Autoimmune Diseases
    • 9.1.4.Blood Disorders
    • 9.1.5.Cardiac Disorders
    • 9.1.6.Neurological Disorders
    • 9.1.7.Diabetes
    • 9.1.8.Others

10.Allogeneic Stem Cell Transplantation Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Research Institutes
    • 10.1.4.Specialty Clinics
    • 10.1.5.Others

11.Allogeneic Stem Cell Transplantation Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Allogeneic Stem Cell Transplantation Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Allogeneic Stem Cell Transplantation Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Celgene Corporation
    • 12.2.2.Mesoblast Ltd.
    • 12.2.3.Pluristem Therapeutics Inc.
    • 12.2.4.MEDIPOST Co., Ltd.
    • 12.2.5.Osiris Therapeutics, Inc.
    • 12.2.6.Cynata Therapeutics Limited
    • 12.2.7.Takeda Pharmaceutical Company Limited
    • 12.2.8.Astellas Pharma Inc.
    • 12.2.9.Cellular Biomedicine Group, Inc.
    • 12.2.10.Biosolution Co., Ltd.
    • 12.2.11.StemCell Technologies Inc.
    • 12.2.12.Caladrius Biosciences, Inc.
    • 12.2.13.ViaCord
    • 12.2.14.Vericel Corporation
    • 12.2.15.Regen Biopharma Inc.
    • 12.2.16.Gamida Cell Ltd.
    • 12.2.17.Histogenics Corporation
    • 12.2.18.BrainStorm Cell Therapeutics Inc.
    • 12.2.19.Lineage Cell Therapeutics, Inc.
    • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us